WHO ICTRP trial
Intra-arterial Lutetium-177- dotatate for treatment of patients with…
NL-OMON49314 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON49314 |
|---|---|
| Public title | Intra-arterial Lutetium-177- dotatate for treatment of patients with neuroendocrine tumor liver metastases |
| Scientific title | Intra-arterial Lutetium-177- dotatate for treatment of patients with neuroendocrine tumor liver metastases - LUTIA |
| Primary sponsor | Universitair Medisch Centrum Utrecht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | neuroendocriene tumoren (graad I&II) liver metastases NET neuroendocrine tumors;10017990;10027476;liver metastases;neuroendocrine tumors |
| Interventions | Treatment will be randomized between selective right or left hepatic artery administration of 177Lu-dotatate (Four administrations of 7.4 GBq; each via the same randomly allocated hepatic artery during angiography). ;Intra-arterial;Liver… |
| Registration date | May 1, 2019 |
| Target size | 26 |
| Secondary IDs | 2017-000369-54;NCT03590119;NL60725.041.17 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: